Our Team

Our diverse team members bring with them extensive work experience and expertise in their respective fields. We are dedicated to innovating non-invasive clinical applications for early detection of cancer. We are committed to rigorous testing, data-driven processing, accurate unbiased reporting, and to engineer highly accurate and reliable diagnostic tools. Our goal is to make a significant impact on improving the survivability of cancer.

Thomas Long 
CEO, CFO, Cofounder

Tom drives business direction, approves company strategies, and oversees financial and risk planning activities.

Cherylle Goebel
COO, CSO, Cofounder, SAB Member

Cherylle directs operational strategies and scientific direction, reviews results, and provides risk assessments.

Christopher Louden
CIO, Cofounder, SAB Member

Christopher directs and audits statistical approaches for algorithm development and oversees information technology operations.

Insert Content Template or Symbol
Insert Video

Lung Cancer Proteomics, LLC
105 Washington Street
Michigan City, IN 46360

Bay Area Laboratory
780 Montague Expressway
Building 7, Suite 703
San Jose, CA 95131

LinkedIn - Lung Cancer Proteomics
Twitter - Lung Cancer Proteomics
Facebook - Lung Cancer Proteomics

© 2019 Lung Cancer Proteomics. All rights reserved.

Insert Content Template or Symbol